Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival

Background: This study reports the results of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (dex) in patients with unresectable intrahepatic cholangiocarcinoma (ICC) or hepatocellular carcinoma (HCC) and investigates dynamic contrast-enhanced magnetic resonance imaging (D...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Jarnagin, W. R., Schwartz, L. H., Gultekin, D. H., Gönen, M., Haviland, D., Shia, J., D'Angelica, M., Fong, Y., DeMatteo, R., Tse, A., Blumgart, L. H., Kemeny, N.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2009
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2731015/
https://ncbi.nlm.nih.gov/pubmed/19491285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdp029
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars